Global Immunohematology

Immunohematology Comprehensive Study by Type (Reagents, Analyzers (Automatic and Semi-automatic/Manual)), Application (Blood-Related Diseases, HIV, Hepatitis), Technology (Microplates, Biochips, Gel Cards, Erythrocyte-magnetized technology (EMT), Polymerase Chain Reaction), End-User (Blood Banks, Hospitals, Diagnostic and Reference Laboratories, Academic and Research Institutes) Players and Region - Global Market Outlook to 2028

Immunohematology Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Immunohematology is a branch of medicine that studies the antibodies and antigens found in red blood cells (RBCs) as well as blood transfusions and blood banking. Various immunohematology studies include analyzing blood samples for over 230 antigens found in red blood cells (RBCs), which are classified into two categories: polypeptides and carbohydrates. The screening of blood antigens, Rh factor, plasma, and white blood cell components in donor blood is aided by immunohematology. The processing of blood components for transfusion is generally referred to as blood banking. It helps to prevent deaths from transfusion-related diseases including HIV and thalassemia. Increased investment in the construction of blood banks by both public and private entities is a key factor driving market growth. Furthermore, blood banks are gaining popularity and have the ability to boost immunohematology product sales. Antigen-antibody reactions that can cause hemolysis or RBC agglutination are tested in most immunohematology instruments. Leading immunohematology companies are developing technologically advanced immunohematology instruments to improve the accuracy of various tests and services conducted in end-user organizations like laboratories and hospitals.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledBio-Rad Laboratories (United States), Immucor, Inc (United States), Grifols S.A. (Spain), Hologic, Inc (United States), Becton Dickinson and Company (United States), Siemens Healthineers (Germany), Thermo Fisher Scientific (United States), Abbott Laboratories (United States), Merck KGaA (Germany) and F. Hoffmann La-Roche Ltd (Switzerland)


This growth is primarily driven by An Increasing Number of Blood Banks and Trauma Centers in Developed Countries, Increasing Incidence of Trauma and Immunohematological disorders and The rising prevalence rate of various Hematological disorders.

Globally, a noticeable market trend is evident Use of Mono-Clonal Reagents Major Players, such as Bio-Rad Laboratories (United States), Immucor, Inc (United States), Grifols S.A. (Spain), Hologic, Inc (United States), Becton Dickinson and Company (United States), Siemens Healthineers (Germany), Thermo Fisher Scientific (United States), Abbott Laboratories (United States), Merck KGaA (Germany) and F. Hoffmann La-Roche Ltd (Switzerland), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.

Key Developments in the Market:
In March 2021, Roche announced a merger with GenMark Diagnostics to expand its molecular diagnostic tests. This strategy will benefit the company in expanding its product portfolio and achieving further growth in the market.
April 2020 - Bio-Rad Laboratories a global leader in life science research and clinical diagnostic products, announced that the company is launching a blood-based immunoassay kit to identify antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19

Regulatory Insights:
In the United States, the Food and Drug Administration (FDA) oversees the regulation of immunohematology products. The FDA sets standards and guidelines for blood products, blood transfusions, and tests used in immunohematology, ensuring their safety and effectiveness.

Influencing Trend:
Use of Mono-Clonal Reagents

Market Growth Drivers:
An Increasing Number of Blood Banks and Trauma Centers in Developed Countries, Increasing Incidence of Trauma and Immunohematological disorders and The rising prevalence rate of various Hematological disorders

Challenges:
Need of Specifically Skilled Professionals and Stringent Regulatory Policies

Restraints:
High Costs of Techniques

Opportunities:
Increasing Number of Blood Donation Awareness Programs in Developing Countries, Rising Worldwide Concerns about Medical Safety and Technological Advancements in Immunohematology

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Immunohematology Market
- Analysis about New Entrants in Immunohematology Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Immunohematology Study Sheds Light on
— The Immunohematology Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Immunohematology industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Immunohematology industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Reagents
  • Analyzers (Automatic and Semi-automatic/Manual)
By Application
  • Blood-Related Diseases
  • HIV
  • Hepatitis
By Technology
  • Microplates
  • Biochips
  • Gel Cards
  • Erythrocyte-magnetized technology (EMT)
  • Polymerase Chain Reaction

By End-User
  • Blood Banks
  • Hospitals
  • Diagnostic and Reference Laboratories
  • Academic and Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. An Increasing Number of Blood Banks and Trauma Centers in Developed Countries
      • 3.2.2. Increasing Incidence of Trauma and Immunohematological disorders
      • 3.2.3. The rising prevalence rate of various Hematological disorders
    • 3.3. Market Challenges
      • 3.3.1. Need of Specifically Skilled Professionals
      • 3.3.2. Stringent Regulatory Policies
    • 3.4. Market Trends
      • 3.4.1. Use of Mono-Clonal Reagents
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Immunohematology, by Type, Application, Technology, End-User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Immunohematology (Value)
      • 5.2.1. Global Immunohematology by: Type (Value)
        • 5.2.1.1. Reagents
        • 5.2.1.2. Analyzers (Automatic and Semi-automatic/Manual)
      • 5.2.2. Global Immunohematology by: Application (Value)
        • 5.2.2.1. Blood-Related Diseases
        • 5.2.2.2. HIV
        • 5.2.2.3. Hepatitis
      • 5.2.3. Global Immunohematology by: Technology (Value)
        • 5.2.3.1. Microplates
        • 5.2.3.2. Biochips
        • 5.2.3.3. Gel Cards
        • 5.2.3.4. Erythrocyte-magnetized technology (EMT)
        • 5.2.3.5. Polymerase Chain Reaction
      • 5.2.4. Global Immunohematology by: End-User (Value)
        • 5.2.4.1. Blood Banks
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Diagnostic and Reference Laboratories
        • 5.2.4.4. Academic and Research Institutes
      • 5.2.5. Global Immunohematology Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Immunohematology: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio-Rad Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Immucor, Inc (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Grifols S.A. (Spain)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Hologic, Inc (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Becton Dickinson and Company (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Siemens Healthineers (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Thermo Fisher Scientific (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Abbott Laboratories (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merck KGaA (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. F. Hoffmann La-Roche Ltd (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Immunohematology Sale, by Type, Application, Technology, End-User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Immunohematology (Value)
      • 7.2.1. Global Immunohematology by: Type (Value)
        • 7.2.1.1. Reagents
        • 7.2.1.2. Analyzers (Automatic and Semi-automatic/Manual)
      • 7.2.2. Global Immunohematology by: Application (Value)
        • 7.2.2.1. Blood-Related Diseases
        • 7.2.2.2. HIV
        • 7.2.2.3. Hepatitis
      • 7.2.3. Global Immunohematology by: Technology (Value)
        • 7.2.3.1. Microplates
        • 7.2.3.2. Biochips
        • 7.2.3.3. Gel Cards
        • 7.2.3.4. Erythrocyte-magnetized technology (EMT)
        • 7.2.3.5. Polymerase Chain Reaction
      • 7.2.4. Global Immunohematology by: End-User (Value)
        • 7.2.4.1. Blood Banks
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Diagnostic and Reference Laboratories
        • 7.2.4.4. Academic and Research Institutes
      • 7.2.5. Global Immunohematology Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Immunohematology: by Type(USD Million)
  • Table 2. Immunohematology Reagents , by Region USD Million (2017-2022)
  • Table 3. Immunohematology Analyzers (Automatic and Semi-automatic/Manual) , by Region USD Million (2017-2022)
  • Table 4. Immunohematology: by Application(USD Million)
  • Table 5. Immunohematology Blood-Related Diseases , by Region USD Million (2017-2022)
  • Table 6. Immunohematology HIV , by Region USD Million (2017-2022)
  • Table 7. Immunohematology Hepatitis , by Region USD Million (2017-2022)
  • Table 8. Immunohematology: by Technology(USD Million)
  • Table 9. Immunohematology Microplates , by Region USD Million (2017-2022)
  • Table 10. Immunohematology Biochips , by Region USD Million (2017-2022)
  • Table 11. Immunohematology Gel Cards , by Region USD Million (2017-2022)
  • Table 12. Immunohematology Erythrocyte-magnetized technology (EMT) , by Region USD Million (2017-2022)
  • Table 13. Immunohematology Polymerase Chain Reaction , by Region USD Million (2017-2022)
  • Table 14. Immunohematology: by End-User(USD Million)
  • Table 15. Immunohematology Blood Banks , by Region USD Million (2017-2022)
  • Table 16. Immunohematology Hospitals , by Region USD Million (2017-2022)
  • Table 17. Immunohematology Diagnostic and Reference Laboratories , by Region USD Million (2017-2022)
  • Table 18. Immunohematology Academic and Research Institutes , by Region USD Million (2017-2022)
  • Table 19. South America Immunohematology, by Country USD Million (2017-2022)
  • Table 20. South America Immunohematology, by Type USD Million (2017-2022)
  • Table 21. South America Immunohematology, by Application USD Million (2017-2022)
  • Table 22. South America Immunohematology, by Technology USD Million (2017-2022)
  • Table 23. South America Immunohematology, by End-User USD Million (2017-2022)
  • Table 24. Brazil Immunohematology, by Type USD Million (2017-2022)
  • Table 25. Brazil Immunohematology, by Application USD Million (2017-2022)
  • Table 26. Brazil Immunohematology, by Technology USD Million (2017-2022)
  • Table 27. Brazil Immunohematology, by End-User USD Million (2017-2022)
  • Table 28. Argentina Immunohematology, by Type USD Million (2017-2022)
  • Table 29. Argentina Immunohematology, by Application USD Million (2017-2022)
  • Table 30. Argentina Immunohematology, by Technology USD Million (2017-2022)
  • Table 31. Argentina Immunohematology, by End-User USD Million (2017-2022)
  • Table 32. Rest of South America Immunohematology, by Type USD Million (2017-2022)
  • Table 33. Rest of South America Immunohematology, by Application USD Million (2017-2022)
  • Table 34. Rest of South America Immunohematology, by Technology USD Million (2017-2022)
  • Table 35. Rest of South America Immunohematology, by End-User USD Million (2017-2022)
  • Table 36. Asia Pacific Immunohematology, by Country USD Million (2017-2022)
  • Table 37. Asia Pacific Immunohematology, by Type USD Million (2017-2022)
  • Table 38. Asia Pacific Immunohematology, by Application USD Million (2017-2022)
  • Table 39. Asia Pacific Immunohematology, by Technology USD Million (2017-2022)
  • Table 40. Asia Pacific Immunohematology, by End-User USD Million (2017-2022)
  • Table 41. China Immunohematology, by Type USD Million (2017-2022)
  • Table 42. China Immunohematology, by Application USD Million (2017-2022)
  • Table 43. China Immunohematology, by Technology USD Million (2017-2022)
  • Table 44. China Immunohematology, by End-User USD Million (2017-2022)
  • Table 45. Japan Immunohematology, by Type USD Million (2017-2022)
  • Table 46. Japan Immunohematology, by Application USD Million (2017-2022)
  • Table 47. Japan Immunohematology, by Technology USD Million (2017-2022)
  • Table 48. Japan Immunohematology, by End-User USD Million (2017-2022)
  • Table 49. India Immunohematology, by Type USD Million (2017-2022)
  • Table 50. India Immunohematology, by Application USD Million (2017-2022)
  • Table 51. India Immunohematology, by Technology USD Million (2017-2022)
  • Table 52. India Immunohematology, by End-User USD Million (2017-2022)
  • Table 53. South Korea Immunohematology, by Type USD Million (2017-2022)
  • Table 54. South Korea Immunohematology, by Application USD Million (2017-2022)
  • Table 55. South Korea Immunohematology, by Technology USD Million (2017-2022)
  • Table 56. South Korea Immunohematology, by End-User USD Million (2017-2022)
  • Table 57. Taiwan Immunohematology, by Type USD Million (2017-2022)
  • Table 58. Taiwan Immunohematology, by Application USD Million (2017-2022)
  • Table 59. Taiwan Immunohematology, by Technology USD Million (2017-2022)
  • Table 60. Taiwan Immunohematology, by End-User USD Million (2017-2022)
  • Table 61. Australia Immunohematology, by Type USD Million (2017-2022)
  • Table 62. Australia Immunohematology, by Application USD Million (2017-2022)
  • Table 63. Australia Immunohematology, by Technology USD Million (2017-2022)
  • Table 64. Australia Immunohematology, by End-User USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Immunohematology, by Type USD Million (2017-2022)
  • Table 66. Rest of Asia-Pacific Immunohematology, by Application USD Million (2017-2022)
  • Table 67. Rest of Asia-Pacific Immunohematology, by Technology USD Million (2017-2022)
  • Table 68. Rest of Asia-Pacific Immunohematology, by End-User USD Million (2017-2022)
  • Table 69. Europe Immunohematology, by Country USD Million (2017-2022)
  • Table 70. Europe Immunohematology, by Type USD Million (2017-2022)
  • Table 71. Europe Immunohematology, by Application USD Million (2017-2022)
  • Table 72. Europe Immunohematology, by Technology USD Million (2017-2022)
  • Table 73. Europe Immunohematology, by End-User USD Million (2017-2022)
  • Table 74. Germany Immunohematology, by Type USD Million (2017-2022)
  • Table 75. Germany Immunohematology, by Application USD Million (2017-2022)
  • Table 76. Germany Immunohematology, by Technology USD Million (2017-2022)
  • Table 77. Germany Immunohematology, by End-User USD Million (2017-2022)
  • Table 78. France Immunohematology, by Type USD Million (2017-2022)
  • Table 79. France Immunohematology, by Application USD Million (2017-2022)
  • Table 80. France Immunohematology, by Technology USD Million (2017-2022)
  • Table 81. France Immunohematology, by End-User USD Million (2017-2022)
  • Table 82. Italy Immunohematology, by Type USD Million (2017-2022)
  • Table 83. Italy Immunohematology, by Application USD Million (2017-2022)
  • Table 84. Italy Immunohematology, by Technology USD Million (2017-2022)
  • Table 85. Italy Immunohematology, by End-User USD Million (2017-2022)
  • Table 86. United Kingdom Immunohematology, by Type USD Million (2017-2022)
  • Table 87. United Kingdom Immunohematology, by Application USD Million (2017-2022)
  • Table 88. United Kingdom Immunohematology, by Technology USD Million (2017-2022)
  • Table 89. United Kingdom Immunohematology, by End-User USD Million (2017-2022)
  • Table 90. Netherlands Immunohematology, by Type USD Million (2017-2022)
  • Table 91. Netherlands Immunohematology, by Application USD Million (2017-2022)
  • Table 92. Netherlands Immunohematology, by Technology USD Million (2017-2022)
  • Table 93. Netherlands Immunohematology, by End-User USD Million (2017-2022)
  • Table 94. Rest of Europe Immunohematology, by Type USD Million (2017-2022)
  • Table 95. Rest of Europe Immunohematology, by Application USD Million (2017-2022)
  • Table 96. Rest of Europe Immunohematology, by Technology USD Million (2017-2022)
  • Table 97. Rest of Europe Immunohematology, by End-User USD Million (2017-2022)
  • Table 98. MEA Immunohematology, by Country USD Million (2017-2022)
  • Table 99. MEA Immunohematology, by Type USD Million (2017-2022)
  • Table 100. MEA Immunohematology, by Application USD Million (2017-2022)
  • Table 101. MEA Immunohematology, by Technology USD Million (2017-2022)
  • Table 102. MEA Immunohematology, by End-User USD Million (2017-2022)
  • Table 103. Middle East Immunohematology, by Type USD Million (2017-2022)
  • Table 104. Middle East Immunohematology, by Application USD Million (2017-2022)
  • Table 105. Middle East Immunohematology, by Technology USD Million (2017-2022)
  • Table 106. Middle East Immunohematology, by End-User USD Million (2017-2022)
  • Table 107. Africa Immunohematology, by Type USD Million (2017-2022)
  • Table 108. Africa Immunohematology, by Application USD Million (2017-2022)
  • Table 109. Africa Immunohematology, by Technology USD Million (2017-2022)
  • Table 110. Africa Immunohematology, by End-User USD Million (2017-2022)
  • Table 111. North America Immunohematology, by Country USD Million (2017-2022)
  • Table 112. North America Immunohematology, by Type USD Million (2017-2022)
  • Table 113. North America Immunohematology, by Application USD Million (2017-2022)
  • Table 114. North America Immunohematology, by Technology USD Million (2017-2022)
  • Table 115. North America Immunohematology, by End-User USD Million (2017-2022)
  • Table 116. United States Immunohematology, by Type USD Million (2017-2022)
  • Table 117. United States Immunohematology, by Application USD Million (2017-2022)
  • Table 118. United States Immunohematology, by Technology USD Million (2017-2022)
  • Table 119. United States Immunohematology, by End-User USD Million (2017-2022)
  • Table 120. Canada Immunohematology, by Type USD Million (2017-2022)
  • Table 121. Canada Immunohematology, by Application USD Million (2017-2022)
  • Table 122. Canada Immunohematology, by Technology USD Million (2017-2022)
  • Table 123. Canada Immunohematology, by End-User USD Million (2017-2022)
  • Table 124. Mexico Immunohematology, by Type USD Million (2017-2022)
  • Table 125. Mexico Immunohematology, by Application USD Million (2017-2022)
  • Table 126. Mexico Immunohematology, by Technology USD Million (2017-2022)
  • Table 127. Mexico Immunohematology, by End-User USD Million (2017-2022)
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Immunohematology: by Type(USD Million)
  • Table 139. Immunohematology Reagents , by Region USD Million (2023-2028)
  • Table 140. Immunohematology Analyzers (Automatic and Semi-automatic/Manual) , by Region USD Million (2023-2028)
  • Table 141. Immunohematology: by Application(USD Million)
  • Table 142. Immunohematology Blood-Related Diseases , by Region USD Million (2023-2028)
  • Table 143. Immunohematology HIV , by Region USD Million (2023-2028)
  • Table 144. Immunohematology Hepatitis , by Region USD Million (2023-2028)
  • Table 145. Immunohematology: by Technology(USD Million)
  • Table 146. Immunohematology Microplates , by Region USD Million (2023-2028)
  • Table 147. Immunohematology Biochips , by Region USD Million (2023-2028)
  • Table 148. Immunohematology Gel Cards , by Region USD Million (2023-2028)
  • Table 149. Immunohematology Erythrocyte-magnetized technology (EMT) , by Region USD Million (2023-2028)
  • Table 150. Immunohematology Polymerase Chain Reaction , by Region USD Million (2023-2028)
  • Table 151. Immunohematology: by End-User(USD Million)
  • Table 152. Immunohematology Blood Banks , by Region USD Million (2023-2028)
  • Table 153. Immunohematology Hospitals , by Region USD Million (2023-2028)
  • Table 154. Immunohematology Diagnostic and Reference Laboratories , by Region USD Million (2023-2028)
  • Table 155. Immunohematology Academic and Research Institutes , by Region USD Million (2023-2028)
  • Table 156. South America Immunohematology, by Country USD Million (2023-2028)
  • Table 157. South America Immunohematology, by Type USD Million (2023-2028)
  • Table 158. South America Immunohematology, by Application USD Million (2023-2028)
  • Table 159. South America Immunohematology, by Technology USD Million (2023-2028)
  • Table 160. South America Immunohematology, by End-User USD Million (2023-2028)
  • Table 161. Brazil Immunohematology, by Type USD Million (2023-2028)
  • Table 162. Brazil Immunohematology, by Application USD Million (2023-2028)
  • Table 163. Brazil Immunohematology, by Technology USD Million (2023-2028)
  • Table 164. Brazil Immunohematology, by End-User USD Million (2023-2028)
  • Table 165. Argentina Immunohematology, by Type USD Million (2023-2028)
  • Table 166. Argentina Immunohematology, by Application USD Million (2023-2028)
  • Table 167. Argentina Immunohematology, by Technology USD Million (2023-2028)
  • Table 168. Argentina Immunohematology, by End-User USD Million (2023-2028)
  • Table 169. Rest of South America Immunohematology, by Type USD Million (2023-2028)
  • Table 170. Rest of South America Immunohematology, by Application USD Million (2023-2028)
  • Table 171. Rest of South America Immunohematology, by Technology USD Million (2023-2028)
  • Table 172. Rest of South America Immunohematology, by End-User USD Million (2023-2028)
  • Table 173. Asia Pacific Immunohematology, by Country USD Million (2023-2028)
  • Table 174. Asia Pacific Immunohematology, by Type USD Million (2023-2028)
  • Table 175. Asia Pacific Immunohematology, by Application USD Million (2023-2028)
  • Table 176. Asia Pacific Immunohematology, by Technology USD Million (2023-2028)
  • Table 177. Asia Pacific Immunohematology, by End-User USD Million (2023-2028)
  • Table 178. China Immunohematology, by Type USD Million (2023-2028)
  • Table 179. China Immunohematology, by Application USD Million (2023-2028)
  • Table 180. China Immunohematology, by Technology USD Million (2023-2028)
  • Table 181. China Immunohematology, by End-User USD Million (2023-2028)
  • Table 182. Japan Immunohematology, by Type USD Million (2023-2028)
  • Table 183. Japan Immunohematology, by Application USD Million (2023-2028)
  • Table 184. Japan Immunohematology, by Technology USD Million (2023-2028)
  • Table 185. Japan Immunohematology, by End-User USD Million (2023-2028)
  • Table 186. India Immunohematology, by Type USD Million (2023-2028)
  • Table 187. India Immunohematology, by Application USD Million (2023-2028)
  • Table 188. India Immunohematology, by Technology USD Million (2023-2028)
  • Table 189. India Immunohematology, by End-User USD Million (2023-2028)
  • Table 190. South Korea Immunohematology, by Type USD Million (2023-2028)
  • Table 191. South Korea Immunohematology, by Application USD Million (2023-2028)
  • Table 192. South Korea Immunohematology, by Technology USD Million (2023-2028)
  • Table 193. South Korea Immunohematology, by End-User USD Million (2023-2028)
  • Table 194. Taiwan Immunohematology, by Type USD Million (2023-2028)
  • Table 195. Taiwan Immunohematology, by Application USD Million (2023-2028)
  • Table 196. Taiwan Immunohematology, by Technology USD Million (2023-2028)
  • Table 197. Taiwan Immunohematology, by End-User USD Million (2023-2028)
  • Table 198. Australia Immunohematology, by Type USD Million (2023-2028)
  • Table 199. Australia Immunohematology, by Application USD Million (2023-2028)
  • Table 200. Australia Immunohematology, by Technology USD Million (2023-2028)
  • Table 201. Australia Immunohematology, by End-User USD Million (2023-2028)
  • Table 202. Rest of Asia-Pacific Immunohematology, by Type USD Million (2023-2028)
  • Table 203. Rest of Asia-Pacific Immunohematology, by Application USD Million (2023-2028)
  • Table 204. Rest of Asia-Pacific Immunohematology, by Technology USD Million (2023-2028)
  • Table 205. Rest of Asia-Pacific Immunohematology, by End-User USD Million (2023-2028)
  • Table 206. Europe Immunohematology, by Country USD Million (2023-2028)
  • Table 207. Europe Immunohematology, by Type USD Million (2023-2028)
  • Table 208. Europe Immunohematology, by Application USD Million (2023-2028)
  • Table 209. Europe Immunohematology, by Technology USD Million (2023-2028)
  • Table 210. Europe Immunohematology, by End-User USD Million (2023-2028)
  • Table 211. Germany Immunohematology, by Type USD Million (2023-2028)
  • Table 212. Germany Immunohematology, by Application USD Million (2023-2028)
  • Table 213. Germany Immunohematology, by Technology USD Million (2023-2028)
  • Table 214. Germany Immunohematology, by End-User USD Million (2023-2028)
  • Table 215. France Immunohematology, by Type USD Million (2023-2028)
  • Table 216. France Immunohematology, by Application USD Million (2023-2028)
  • Table 217. France Immunohematology, by Technology USD Million (2023-2028)
  • Table 218. France Immunohematology, by End-User USD Million (2023-2028)
  • Table 219. Italy Immunohematology, by Type USD Million (2023-2028)
  • Table 220. Italy Immunohematology, by Application USD Million (2023-2028)
  • Table 221. Italy Immunohematology, by Technology USD Million (2023-2028)
  • Table 222. Italy Immunohematology, by End-User USD Million (2023-2028)
  • Table 223. United Kingdom Immunohematology, by Type USD Million (2023-2028)
  • Table 224. United Kingdom Immunohematology, by Application USD Million (2023-2028)
  • Table 225. United Kingdom Immunohematology, by Technology USD Million (2023-2028)
  • Table 226. United Kingdom Immunohematology, by End-User USD Million (2023-2028)
  • Table 227. Netherlands Immunohematology, by Type USD Million (2023-2028)
  • Table 228. Netherlands Immunohematology, by Application USD Million (2023-2028)
  • Table 229. Netherlands Immunohematology, by Technology USD Million (2023-2028)
  • Table 230. Netherlands Immunohematology, by End-User USD Million (2023-2028)
  • Table 231. Rest of Europe Immunohematology, by Type USD Million (2023-2028)
  • Table 232. Rest of Europe Immunohematology, by Application USD Million (2023-2028)
  • Table 233. Rest of Europe Immunohematology, by Technology USD Million (2023-2028)
  • Table 234. Rest of Europe Immunohematology, by End-User USD Million (2023-2028)
  • Table 235. MEA Immunohematology, by Country USD Million (2023-2028)
  • Table 236. MEA Immunohematology, by Type USD Million (2023-2028)
  • Table 237. MEA Immunohematology, by Application USD Million (2023-2028)
  • Table 238. MEA Immunohematology, by Technology USD Million (2023-2028)
  • Table 239. MEA Immunohematology, by End-User USD Million (2023-2028)
  • Table 240. Middle East Immunohematology, by Type USD Million (2023-2028)
  • Table 241. Middle East Immunohematology, by Application USD Million (2023-2028)
  • Table 242. Middle East Immunohematology, by Technology USD Million (2023-2028)
  • Table 243. Middle East Immunohematology, by End-User USD Million (2023-2028)
  • Table 244. Africa Immunohematology, by Type USD Million (2023-2028)
  • Table 245. Africa Immunohematology, by Application USD Million (2023-2028)
  • Table 246. Africa Immunohematology, by Technology USD Million (2023-2028)
  • Table 247. Africa Immunohematology, by End-User USD Million (2023-2028)
  • Table 248. North America Immunohematology, by Country USD Million (2023-2028)
  • Table 249. North America Immunohematology, by Type USD Million (2023-2028)
  • Table 250. North America Immunohematology, by Application USD Million (2023-2028)
  • Table 251. North America Immunohematology, by Technology USD Million (2023-2028)
  • Table 252. North America Immunohematology, by End-User USD Million (2023-2028)
  • Table 253. United States Immunohematology, by Type USD Million (2023-2028)
  • Table 254. United States Immunohematology, by Application USD Million (2023-2028)
  • Table 255. United States Immunohematology, by Technology USD Million (2023-2028)
  • Table 256. United States Immunohematology, by End-User USD Million (2023-2028)
  • Table 257. Canada Immunohematology, by Type USD Million (2023-2028)
  • Table 258. Canada Immunohematology, by Application USD Million (2023-2028)
  • Table 259. Canada Immunohematology, by Technology USD Million (2023-2028)
  • Table 260. Canada Immunohematology, by End-User USD Million (2023-2028)
  • Table 261. Mexico Immunohematology, by Type USD Million (2023-2028)
  • Table 262. Mexico Immunohematology, by Application USD Million (2023-2028)
  • Table 263. Mexico Immunohematology, by Technology USD Million (2023-2028)
  • Table 264. Mexico Immunohematology, by End-User USD Million (2023-2028)
  • Table 265. Research Programs/Design for This Report
  • Table 266. Key Data Information from Secondary Sources
  • Table 267. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Immunohematology: by Type USD Million (2017-2022)
  • Figure 5. Global Immunohematology: by Application USD Million (2017-2022)
  • Figure 6. Global Immunohematology: by Technology USD Million (2017-2022)
  • Figure 7. Global Immunohematology: by End-User USD Million (2017-2022)
  • Figure 8. South America Immunohematology Share (%), by Country
  • Figure 9. Asia Pacific Immunohematology Share (%), by Country
  • Figure 10. Europe Immunohematology Share (%), by Country
  • Figure 11. MEA Immunohematology Share (%), by Country
  • Figure 12. North America Immunohematology Share (%), by Country
  • Figure 13. Global Immunohematology share by Players 2022 (%)
  • Figure 14. Global Immunohematology share by Players (Top 3) 2022(%)
  • Figure 15. Global Immunohematology share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bio-Rad Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio-Rad Laboratories (United States) Revenue: by Geography 2022
  • Figure 19. Immucor, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 20. Immucor, Inc (United States) Revenue: by Geography 2022
  • Figure 21. Grifols S.A. (Spain) Revenue, Net Income and Gross profit
  • Figure 22. Grifols S.A. (Spain) Revenue: by Geography 2022
  • Figure 23. Hologic, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 24. Hologic, Inc (United States) Revenue: by Geography 2022
  • Figure 25. Becton Dickinson and Company (United States) Revenue, Net Income and Gross profit
  • Figure 26. Becton Dickinson and Company (United States) Revenue: by Geography 2022
  • Figure 27. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 28. Siemens Healthineers (Germany) Revenue: by Geography 2022
  • Figure 29. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 30. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 31. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 33. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 35. F. Hoffmann La-Roche Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. F. Hoffmann La-Roche Ltd (Switzerland) Revenue: by Geography 2022
  • Figure 37. Global Immunohematology: by Type USD Million (2023-2028)
  • Figure 38. Global Immunohematology: by Application USD Million (2023-2028)
  • Figure 39. Global Immunohematology: by Technology USD Million (2023-2028)
  • Figure 40. Global Immunohematology: by End-User USD Million (2023-2028)
  • Figure 41. South America Immunohematology Share (%), by Country
  • Figure 42. Asia Pacific Immunohematology Share (%), by Country
  • Figure 43. Europe Immunohematology Share (%), by Country
  • Figure 44. MEA Immunohematology Share (%), by Country
  • Figure 45. North America Immunohematology Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio-Rad Laboratories (United States)
  • Immucor, Inc (United States)
  • Grifols S.A. (Spain)
  • Hologic, Inc (United States)
  • Becton Dickinson and Company (United States)
  • Siemens Healthineers (Germany)
  • Thermo Fisher Scientific (United States)
  • Abbott Laboratories (United States)
  • Merck KGaA (Germany)
  • F. Hoffmann La-Roche Ltd (Switzerland)
Select User Access Type

Key Highlights of Report


May 2023 204 Pages 68 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Immunohematology Quantitative research analysis
Global Immunohematology Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Immunohematology market are Bio-Rad Laboratories (United States), Immucor, Inc (United States), Grifols S.A. (Spain), Hologic, Inc (United States), Becton Dickinson and Company (United States), Siemens Healthineers (Germany), Thermo Fisher Scientific (United States), Abbott Laboratories (United States), Merck KGaA (Germany) and F. Hoffmann La-Roche Ltd (Switzerland), to name a few.
is dominating the Immunohematology Market.
"Need of Specifically Skilled Professionals " is seen as one of the major challenges by many Industry Players of Immunohematology Market
The Immunohematology market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Immunohematology market is expected to see a steady growth rate during projected year 2022 to 2028.

Know More About Global Immunohematology Report?

Have a Query? Click Here

Other Related Reports

Viral Clearance Comprehensive Study by Type (Viral Detection Method, Viral Removal Method, Viral Inactivation Method), Application (Blood & Blood Products, Cellular & Gene Therapy Products, Stem Cell...
$ 3750
Feed Enzymes Comprehensive Study by Type (Phytase, Protease, Carbohydrase, Others), Application (Ruminants, Swine, Poultry, Aquatic animals, Others (equine and pets)), Form (Liquid, Dry), Source (Mic...
$ 3350
Double Barreled Antibodies Drug Comprehensive Study by Type (Removab, BLINCYTO, Others), Application (Lung Cancer, Brain Cancer, Liver Cancer, Others), End Users (Clinical research, Hospitals and cli...
$ 3350
Asparaginase Comprehensive Study by Type (E. Coli Asparaginase, Erwinia Asparaginase, Pegylated Asparaginase), Application (Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia), Distribution Channel...
$ 3450
CBCT System Comprehensive Study by Type (Image Intensifier Detector, Flat-Panel Imager Detector), Components (Hardware, Software), End Users (Hospitals & Clinics, Imaging Centre, Academic and Researc...
$ 3500
Food Biotechnology Comprehensive Study by Type (Transgenic Crops, Synthetic Biology Derived Products), Food Source (Animal, Plant, Others) Players and Region - Global Market Outlook to 2030
$ 3500